Cart
sales@molnova.com
LIMK-IN-22j
CAS No. 1116571-01-7
LIMK-IN-22j( LIMK IN 22j | LIMKIN22j | LIMK inhibitor 22j | LIMK inhibitor-22j )
Catalog No. M27778 CAS No. 1116571-01-7
LIMK-IN-22j is an effective and selective inhibitor of LIMK.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 54 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 39 | In Stock |
|
| 10MG | 56 | In Stock |
|
| 25MG | 102 | In Stock |
|
| 50MG | 142 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLIMK-IN-22j
-
NoteResearch use only, not for human use.
-
Brief DescriptionLIMK-IN-22j is an effective and selective inhibitor of LIMK.
-
DescriptionLIMK-IN-22j is an effective and selective inhibitor of LIMK.
-
In Vitro——
-
In Vivo——
-
SynonymsLIMK IN 22j | LIMKIN22j | LIMK inhibitor 22j | LIMK inhibitor-22j
-
PathwayCell Cycle/DNA Damage
-
TargetLIM Kinase (LIMK)
-
Recptortubulin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1116571-01-7
-
Formula Weight453.34
-
Molecular FormulaC20H21BrN8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=CNC2=NC=NC(N3C[C@H](C)N(/C(NC4=CC=CC(Br)=C4)=N\C#N)CC3)=C21
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gang Li. Design, synthesis, and bioevaluation of pyrazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent anticancer activities. Eur J Med Chem. 2020 Sep 15;202:112519.
molnova catalog
related products
-
T.cruzi Inhibitor
T.cruzi Inhibitor is a Trypanosoma cruzi inhibitor.
-
TH 257
TH 257 is a Potent and selective allosteric LIMK 1/2 inhibitor(LIMK1 and LIMK2 IC50 of 84 nM and 39 nM).
-
R-10015
R-10015 is a potent and selective inhibitor of LIM domain kinase (LIMK) and binds to the ATP-binding pocket(IC50 of 38 nM for human LIMK1),and a broad-spectrum antiviral compound for HIV infection.R10015 as a lead compound that blocks LIMK activity by binding to the ATP-binding pocket.?
